Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
American Journal of Therapeutics(3)
Archivos Venezolanos de Farmacologia y Terapeutica(3)
American journal of therapeutics(1)
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(4)
Fisiología humana(2)
Salud y seguridad personal(2)
Bioquímica(1)
Origen
google(1)
Front-line medicines used in the treatment of tuberculosis
ArticleAbstract: Tuberculosis has emerged as an enormous global public health epidemic. Worldwide, it is the second lPalabras claves:Estreptomicin, Ethambutol, isoniazid, M. Tuberculosis, Pyrazinamide, rifampinAutores:Arráiz N., Bermúdez F.A., Leal E.M., Rodriguez M., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusMolecular mechanisms of endothelial dysfunction: From nitric oxide synthesis to ADMA inhibition
ArticleAbstract: Endothelial dysfunction symbolizes several pathological conditions, including altered anticoag-ulantPalabras claves:cardiovascular diseases, endothelial dysfunction, Nitric oxide, nitric oxide synthaseAutores:Acosta A., Acosta G., Andara C., Añez J., Bermúdez F.A., Cano-Ponce C., Hernández-Hernandez R., Israili Z.H., Leal E.M., Manuel V., Valmore BermúdezFuentes:scopusHomeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes
ArticleAbstract: Type 2 diabetes mellitus is a metabolic disorder that results from defects in both insulin secretionPalabras claves:Free fatty acids, HOMA, Insulin, Insulin Resistance, Type 2 Diabetes mellitusAutores:Acosta K., Aparicio D., Arráiz N., Bermúdez F.A., Briceño C., Bustamante M., Cabrera M., Cano R.A., Cano-Ponce C., Gómez J., Hernández-Hernandez R., Joselyn Zula, Leal E.M., Manuel V., Mengual-Moreno E., Rodriguez M., Valdelamar L., Valmore BermúdezFuentes:googlescopusMolecular biology of glucose transporters: Classification, structure and distribution
ReviewAbstract: Hexoses like glucose, galactose and fructose serve as basic fuel molecules for eucaryotic cells. ThePalabras claves:Co-transporter, Facilitative diffusion, glucose, Glut, SGLT-1, SGLT-2, TransporterAutores:Acosta A., Amell A., Andara C., Añez J., Angulo V., Arráiz N., Bermúdez F.A., Carrillo M., Leal E.M., Linares S., Martins G., Mengual-Moreno E., Rodriguez M., Seyfi H.A., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusPharmacologic management of isolated low high-density lipoprotein syndrome
ArticleAbstract: High-density lipoprotein (HDL) cholesterol is a heterogeneous group of lipoproteins exhibiting a varPalabras claves:atherosclerosis, cholesterol, Coronary artery disease, dyslipidemia, HDLc, Reverse cholesterol transportAutores:Acosta L., Amell A., Arráiz N., Bermúdez F.A., Cano R.A., Cano-Ponce C., Finol F., Hernández-Hernandez R., Hidalgo J., Kendall P., Manuel V., Pabón M.R., Reyna-Villasmil N., Valmore BermúdezFuentes:scopusPharmacologic treatment of obesity: Present, past and future
ReviewAbstract: Obesity is a chronic, stigmatized and costly disease that is rarely curable and is increasing in prePalabras claves:body mass index, Energetic balance, Noradrenegic agents, obesity, Orlistat, Serotoninergic agents, SibutraminAutores:Amell A., Bermúdez F.A., Cabrera M., Leal E.M., Mengual-Moreno E., Rodriguez M., Silva C., Toledo A., Valdelamar L., Valmore BermúdezFuentes:scopusTrimetazidine diminishes fasting glucose in rats with fasting hyperglycemia: a preliminary study.
ArticleAbstract: Trimetazidine is a drug with cardioprotective properties used in coronary artery disease. Its effectPalabras claves:Autores:Ambard M.J., Bermúdez F.A., Cano-Ponce C., Contreras F., Escalona D., Medina M.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopus